Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Front Oncol ; 14: 1298109, 2024.
Article in English | MEDLINE | ID: mdl-38515573

ABSTRACT

Multiple primary malignant neoplasms are a rare gynecologic malignancy; particularly, cases originating from the heterologous organs, such as the ovary and cervix. Here, we report a case of two primary malignant neoplasms in a patient who had undergone laparoscopic radical hysterectomy + bilateral salpingo-oophorectomy + pelvic lymph node dissection + para-aortic lymphadenectomy + appendectomy + omentectomy + metastasectomy under general anesthesia. The patient experienced complete remission after six courses of postoperative chemotherapy with a standard Taxol and Carboplatin regimen. Genetic testing was performed to detect BRCA2 mutations, and poly (ADP-ribose) polymerase (PARP) inhibitors were used for maintenance therapy.

2.
World J Clin Cases ; 9(24): 7110-7116, 2021 Aug 26.
Article in English | MEDLINE | ID: mdl-34540966

ABSTRACT

BACKGROUND: Extramedullary plasmacytoma (EMP), a variant form of myeloma, is a rare solid plasma cell tumor that originates from the bone marrow hematopoietic tissue and accounts for about 3% of all plasma cell tumors. EMP can affect various tissues and organs, about 90% of which is found in the head and neck. However, EMP in the reproductive organs is rare, and is difficult to be distinguished from other primary or metastatic genital tumors according to clinical symptoms and imaging findings. CASE SUMMARY: Herein, we report a case with coexistence of EMP and squamous cell carcinoma in the cervix. The first histopathological report of neoplasms on the surface of the cervix and vagina showed an EMP. Both ultrasound and pelvic enhanced magnetic resonance imaging (MRI) indicated that there was a tumor in the cervix. Thus, another cervical biopsy and pathological examination were performed, which indicated EMP combined with squamous cell carcinoma. Then, the patient underwent extensive total hysterectomy (type C1) + systemic lymph node dissection and received 25 external pelvic irradiations with a dose of 50 Gy following surgery. During 2-year follow-up, no recurrence was reported. CONCLUSION: In conclusion, EMP involving the reproductive system is relatively rare. In this case, MRI, B-ultrasound, and cervical canal scraping were used to further determine the diagnosis of EMP combined with squamous cell carcinoma. The patient had improved prognosis after appropriate treatments.

3.
Biomed Res Int ; 2021: 7273846, 2021.
Article in English | MEDLINE | ID: mdl-34258281

ABSTRACT

This study is aimed to investigate the mechanisms of radiation-induced mouse models of premature ovarian insufficiency (POI). Wistar female rats were grouped into the control, 3.2 Gy, 4.0 Gy, and 4.8 Gy groups. Overall ovarian functions were assessed with the H&E staining and ELISA. Proinflammatory cytokine secretion was analyzed ELISA, and the reactive oxygen species (ROS) levels were analyzed with immunohistochemistry. Protein expressions were analyzed by Western blot analysis. The 4.0 Gy and 4.8 Gy groups had significantly lower ovarian weight coefficients than the control and 3.2 Gy groups (after only one irradiation therapy). The 3.2 Gy radiation group induced periodic disturbance and hormone change at 4 weeks after radiation. In the 4.0 Gy and 4.8 Gy groups, the preantral follicles and antral follicles were decreased, while Atresia follicles were increased. E2 was decreased, while FSH and LH secretions were increased. The ovaries in the 4.0 Gy group were not completely atrophied, and some preantral follicles remained. Ovarian atrophy and follicular Atresia were found in the 4.8 Gy group. Inflammatory and oxidative markers were upregulated. PI3K and AKT were downregulated in the 4.0 Gy and 4.8 Gy groups, while FOXO3a was upregulated. Ovarian injuries may lead to oxidative damages and inflammatory injuries, downregulate the expression of P13k and Akt, upregulate the expression of FOXO3a, and lead to follicular atresia in the ovary.


Subject(s)
Estrus/radiation effects , Forkhead Box Protein O3/metabolism , Ovarian Follicle/metabolism , Ovary/metabolism , Ovary/radiation effects , Phosphatidylinositol 3-Kinases/metabolism , Primary Ovarian Insufficiency/etiology , Proto-Oncogene Proteins c-akt/metabolism , Radiotherapy/adverse effects , Animals , Cytokines/biosynthesis , Disease Models, Animal , Female , Follicle Stimulating Hormone/metabolism , Follicular Atresia/metabolism , Inflammation , Luteinizing Hormone/metabolism , Oxidative Stress , Primary Ovarian Insufficiency/pathology , Rats , Rats, Wistar , Reactive Oxygen Species
4.
Mol Med Rep ; 23(1)2021 01.
Article in English | MEDLINE | ID: mdl-33179093

ABSTRACT

The aim of the present study was to investigate the effects of the ginsenoside Rg1 on D­galactose (D­gal)­induced mouse models of premature ovarian insufficiency (POI) and the related mechanisms. C57BL/6 female mice were randomly grouped into the following: i) D­gal [subcutaneously (s.c.) 200 mg/kg/d D­gal for 42 days]; ii) Rg1 [intraperitoneally (i.p.) 20 mg/kg/d Rg1 for 28 days]; iii) D­gal + Rg1 (s.c. 200 mg/kg/d D­gal for 42 days followed by i.p. 20 mg/kg/d Rg1 for 28 days); and iv) saline groups (equivalent volume of saline s.c. and i.p.). Hematoxylin and eosin staining and electron microscopy were used to analyze uterine and ovarian morphology. Expression levels of senescence factors (p21, p53 and serine/threonine kinase), secretion of pro­inflammatory cytokines [interleukin (IL)­6, tumor necrosis factor (TNF)­α and IL­1ß] and the activities of oxidation biomarkers [superoxide dismutase (T­SOD), malondialdehyde (MDA) and glutathione peroxidase (GSH­px)] were analyzed. The results showed that mice in the Rg1 + D­gal group had significantly higher uterine and ovarian weight compared with those in the D­gal group. Uterus morphology was also improved, based on the comparison between the D­gal group and the Rg1 + D­gal group. In addition, the Rg1 treatment after D­gal administration significantly decreased the expression of senescence­associated factors, enhanced the activities of anti­oxidant enzymes total T­SOD and GSH­px in addition to reducing TNF­α, IL­1ß, MDA and IL­6 (based on the comparison between the D­gal group and the Rg1 + D­gal group). In conclusion, the present study suggested that the ginsenoside Rg1 improved pathological damages in the ovary and uterus by increasing anti­oxidant and anti­inflammatory abilities whilst reducing the expression of senescence signaling pathways in POI mouse models.


Subject(s)
Galactose/analogs & derivatives , Ginsenosides/administration & dosage , Ovary/metabolism , Primary Ovarian Insufficiency/drug therapy , Uterus/metabolism , Animals , Aurora Kinase B/metabolism , Cellular Senescence/drug effects , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Disease Models, Animal , Female , Galactose/adverse effects , Gene Expression Regulation/drug effects , Ginsenosides/pharmacology , Injections, Intraperitoneal , Mice , Mice, Inbred C57BL , Organ Size/drug effects , Ovary/drug effects , Primary Ovarian Insufficiency/chemically induced , Primary Ovarian Insufficiency/metabolism , Signal Transduction/drug effects , Tumor Suppressor Protein p53/metabolism , Uterus/drug effects
5.
Stem Cell Res Ther ; 8(1): 283, 2017 Dec 19.
Article in English | MEDLINE | ID: mdl-29258619

ABSTRACT

BACKGROUND: Human amnion-derived mesenchymal stem cells (hAD-MSCs) have the features of mesenchymal stem cells (MSCs). Low-intensity pulsed ultrasound (LIPUS) can promote the expression of various growth factors and anti-inflammatory molecules that are necessary to keep the follicle growing and to reduce granulosa cell (GC) apoptosis in the ovary. This study aims to explore the effects of LIPUS-pretreated hAD-MSC transplantation on chemotherapy-induced primary ovarian insufficiency (POI) in rats. METHODS: The animals were divided into control, POI, hAD-MSC treatment, and LIPUS-pretreated hAD-MSC treatment groups. POI rat models were established by intraperitoneal injection of cyclophosphamide (CTX). The hAD-MSCs isolated from the amnion were exposed to LIPUS or sham irradiation for 5 consecutive days and injected into the tail vein of POI rats. Expression and secretion of growth factors promoted by LIPUS in hAD-MSCs were detected by real-time quantitative polymerase chain reaction (RT-qPCR) and enzyme-linked immunosorbent assay (ELISA) in vitro. Estrous cycle, serum sex hormone levels, follicle counts, ovarian pathological changes, GC apoptosis, Bcl2 and Bax expression, and pro-inflammatory cytokine levels in ovaries were examined. RESULTS: Primary hAD-MSCs were successfully isolated from the amnion. LIPUS promoted the expression and secretion of growth factors in hAD-MSCs in vitro. Both hAD-MSC and LIPUS-pretreated hAD-MSC transplantation increased the body and reproductive organ weights, improved ovarian function, and reduced reproductive organ injuries in POI rats. Transplantation of hAD-MSCs increased the Bcl-2/Bax ratio and reduced GC apoptosis and ovarian inflammation induced by chemotherapy in ovaries. These effects could be improved by pretreatment with LIPUS on hAD-MSCs. CONCLUSION: Both hAD-MSC transplantation and LIPUS-pretreated hAD-MSC transplantation can repair ovarian injury and improve ovarian function in rats with chemotherapy-induced POI. LIPUS-pretreated hAD-MSC transplantation is more advantageous for reducing inflammation, improving the local microenvironment, and inhibiting GC apoptosis induced by chemotherapy in ovarian tissue of POI rats.


Subject(s)
Mesenchymal Stem Cell Transplantation/methods , Primary Ovarian Insufficiency/diagnostic imaging , Primary Ovarian Insufficiency/therapy , Transplantation, Homologous/methods , Ultrasonic Waves , Animals , Female , Humans , Primary Ovarian Insufficiency/pathology , Rats
6.
Cell Prolif ; 50(6)2017 Dec.
Article in English | MEDLINE | ID: mdl-28940899

ABSTRACT

OBJECTIVES: This study was to investigate the effect and mechanism of low-intensity pulsed ultrasound (LIPUS) on the proliferation of human amnion-derived mesenchymal stem cells (hAD-MSCs). METHODS: Human amnion-derived mesenchymal stem cells were isolated from the amnion of term placentas and identified by flow cytometry and differentiation culture. Proliferation of hAD-MSCs was investigated by Cell Counting Kit-8, cell cycle and EdU assays. Western blotting was used to determine the protein expression levels. RESULTS: Human amnion-derived mesenchymal stem cells were successfully isolated from the amnion and identified as multipotent mesenchymal stem cells. Low-intensity pulsed ultrasound promoted the proliferation of hAD-MSCs. Cell cycle analysis showed that LIPUS promoted cells to enter S and G2/M phases from G0/G1 phase. Western blot results showed that LIPUS promoted the phosphorylation and activation of ERK1/2 and Akt and significantly upregulated expression of cyclin D1, cyclin E1, cyclin A2 and cyclin B1. ERK1/2 inhibitor (U0126) and PI3K inhibitor (LY294002) significantly reduced LIPUS-induced phosphorylation of ERK1/2 and Akt, respectively, which in turn reduced the LIPUS-induced proliferation of hAD-MSCs. CONCLUSIONS: Low-intensity pulsed ultrasound can promote the proliferation of hAD-MSCs, and ERK1/2 and PI3K-Akt signalling pathways may play important roles in this process.


Subject(s)
Cell Proliferation/physiology , Mesenchymal Stem Cells/cytology , Signal Transduction , Amnion/metabolism , Cell Cycle/physiology , Cell Differentiation/physiology , Cells, Cultured , Humans , MAP Kinase Signaling System , Mitogen-Activated Protein Kinase 3/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Phosphorylation , Ultrasonic Waves
7.
Exp Biol Med (Maywood) ; 242(7): 683-691, 2017 04.
Article in English | MEDLINE | ID: mdl-28178855

ABSTRACT

This study aims to investigate the effect as well as mechanism of ginsenoside Rg1 (Rg1) on premature ovarian failure (POF) induced by d-galactose (d-gal) in mice. C57BL/6 female mice were divided into four groups randomly, which were the saline group, the d-gal group, the d-gal + Rg1 group, and the Rg1 group. Body weight was recorded. Overall ovarian function including estrous cycles, sex hormone secretion, ovarian follicle development, and ovarian morphology was analyzed by H&E staining and ELISA. Effect of Rg1 on aging was determined by analyzing the activities of oxidation-associated biomarkers, pro-inflammatory cytokine secretion, expression of senescence-associated proteins, and fertility. Compared with the d-gal group, in Rg1 + d-gal group, body weight was increased significantly, estrous cycle block was released, and fertility and the morphology of ovaries were restored. And, Rg1 treatment after d-gal administration significantly reduced senescence-associated protein expression, increased the activity of total superoxide dismutase and glutathione peroxidase from bovine erythrocyte, and induced higher follicle stimulating hormone receptor protein expression. Additionally, the expression levels of malondialdehyde, interleukin-1ß, tumor necrosis factor-α, and interleukin-6 were significantly decreased. Together, Rg1 improves mouse fertility and reduces ovarian pathological damage in d-gal-induced POF model possibly through enhancing anti-inflammatory and antioxidant capacities and reducing expression of senescence signal pathway proteins. Impact statement Ginsenoside Rg1 (Rg1) is a kind of natural estrogen and it has antioxidation and antiaging effects. However, whether Rg1 has effects on premature ovarian failure (POF) is still not clear. In this study, aging model induced by d-galactose was used to mimic POF. The effect and possible mechanism of Rg1 on ovary aging was investigated. We found that Rg1 treatment up-regulated the expression of follicle stimulating hormone receptor and down-regulated senescence-associated protein expression in granule cells of POF mice. Particularly, Rg1 improved fertility ability and reduced ovarian pathological damages by its antioxidative and anti-inflammation capacity. Thus, Rg1 enhances the antiaging ability of ovary and fertility ability of POF mice through enhancing the anti-inflammatory and antioxidant capacities of ovary.


Subject(s)
Fertility/drug effects , Ginsenosides/therapeutic use , Primary Ovarian Insufficiency/drug therapy , Animals , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Estrous Cycle/drug effects , Female , Galactose/pharmacology , Mice , Mice, Inbred C57BL , Ovarian Follicle/drug effects , Ovarian Follicle/growth & development , Ovary/drug effects , Ovary/pathology , Primary Ovarian Insufficiency/chemically induced , Primary Ovarian Insufficiency/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...